| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PAVMPAVmed Inc. | 8.06M | 8.75 | 17.64 | 22.15% | -217914.55% | -245.07% | ||
| SMLRSemler Scientific, Inc. | 310.75M | 20.33 | 3.96 | -17.44% | 130.8% | 10.51% | 0.00 | |
| BJDXBluejay Diagnostics, Inc. | 1.18M | 0.65 | -0.02 | -185.51% | 0.04 | |||
| HSCSHeartSciences Inc. | 10.17M | 3.20 | -0.34 | -76.61% | -1042.38% | -216.05% | 14.55 | |
| LUCDLucid Diagnostics Inc. | 163.87M | 1.25 | -1.19 | 79% | -8.6% | -404.1% | 3.94 | |
| BMRABiomerica, Inc. | 8.09M | 2.68 | -1.24 | -1.92% | -90.29% | -90.76% | 0.11 | |
| MDAISpectral AI, Inc. | 49.41M | 1.61 | -1.89 | 63.83% | -70.64% | |||
| CODXCo-Diagnostics, Inc. | 6.12M | 2.92 | -2.35 | -42.53% | -63.36% | -80.8% | 0.04 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 377K | 2.45M | 3M |
| Revenue Growth % | - | - | - | - | - | - | - | -0.25% | 5.5% | 0.22% |
| Cost of Goods Sold | 0 | 3.79K | 7.11K | 9.79K | 14.23K | 0 | 585K | 3.61M | 6.42M | 6.04M |
| COGS % of Revenue | - | - | - | - | - | - | 1.17% | 9.59% | 2.62% | 2.02% |
| Gross Profit | 0 | -3.79K | -7.11K | -9.79K | -14.23K | 0 | -85K | -3.24M | -3.97M | -3.04M |
| Gross Margin % | - | - | - | - | - | - | -0.17% | -8.59% | -1.62% | -1.02% |
| Gross Profit Growth % | - | - | -0.87% | -0.38% | -0.45% | 1% | - | -37.08% | -0.23% | 0.23% |
| Operating Expenses | 1.78M | 5.65M | 8.03M | 10.56M | 14.3M | 23.35M | 54.31M | 87.85M | 64.83M | 41.44M |
| OpEx % of Revenue | - | - | - | - | - | - | 108.62% | 233.02% | 26.44% | 13.84% |
| Selling, General & Admin | 1.29M | 3.93M | 5.42M | 6.31M | 7.66M | 12.39M | 34.46M | 60.73M | 48.53M | 36.15M |
| SG&A % of Revenue | - | - | - | - | - | - | 68.92% | 161.08% | 19.79% | 12.07% |
| Research & Development | 489.33K | 1.72M | 2.62M | 4.25M | 6.63M | 10.96M | 19.85M | 25.34M | 14.28M | 5.93M |
| R&D % of Revenue | - | - | - | - | - | - | 39.69% | 67.21% | 5.82% | 1.98% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.78M | 2.02M | -639K |
| Operating Income | -1.78M | -5.65M | -8.03M | -10.56M | -14.3M | -23.35M | -54.39M | -91.09M | -68.8M | -44.49M |
| Operating Margin % | - | - | - | - | - | - | -108.79% | -241.61% | -28.06% | -14.85% |
| Operating Income Growth % | -3.21% | -2.18% | -0.42% | -0.31% | -0.35% | -0.63% | -1.33% | -0.67% | 0.24% | 0.35% |
| EBITDA | 0 | -5.65M | -8.03M | -10.55M | -14.28M | -23.33M | -54.17M | -88.63M | -65.86M | -43.29M |
| EBITDA Margin % | - | - | - | - | - | - | -108.33% | -235.09% | -26.86% | -14.45% |
| EBITDA Growth % | - | - | -0.42% | -0.31% | -0.35% | -0.63% | -1.32% | -0.64% | 0.26% | 0.34% |
| D&A (Non-Cash Add-back) | 1.78M | 3.79K | 7.11K | 9.79K | 14.23K | 23K | 226K | 2.46M | 2.93M | 1.2M |
| EBIT | -1.78M | -5.65M | -8.79M | -15.17M | -16.69M | -23.35M | -56.13M | -101.96M | -78.67M | 28.47M |
| Net Interest Income | 0 | 0 | 0 | 0 | 333 | 0 | 0 | -1.11M | -84K | 209K |
| Interest Income | 0 | 0 | 0 | 0 | 33K | 53K | 0 | 169K | 505K | 254K |
| Interest Expense | 0 | 0 | 724.68K | 2.39M | 32.67K | 53K | 0 | 1.28M | 589K | 45K |
| Other Income/Expense | 0 | 0 | -1.49M | -7.61M | -2.97M | -12.54M | -1.73M | -12.15M | -10.47M | 72.91M |
| Pretax Income | -1.78M | -5.65M | -9.52M | -18.17M | -17.27M | -35.89M | -56.13M | -103.24M | -79.26M | 28.43M |
| Pretax Margin % | - | - | - | - | - | - | -112.25% | -273.84% | -32.33% | 9.49% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 0.99% | 0.92% | 0.96% | 0.9% | 0.86% | 0.81% | 1.4% |
| Net Income | -1.78M | -5.65M | -9.52M | -17.97M | -15.93M | -34.28M | -50.35M | -88.98M | -64.17M | 39.79M |
| Net Margin % | - | - | - | - | - | - | -100.69% | -236.03% | -26.17% | 13.29% |
| Net Income Growth % | -2.24% | -2.18% | -0.68% | -0.89% | 0.11% | -1.15% | -0.47% | -0.77% | 0.28% | 1.62% |
| Net Income (Continuing) | -1.78M | -5.65M | -9.52M | -18.17M | -17.27M | -35.89M | -56.13M | -103.24M | -79.26M | 28.43M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | -161.51K | -814.28K | -2.37M | 17.75M | 20.61M | 29.81M | -4.54M |
| EPS (Diluted) | -2.00 | -6.60 | -11.55 | -12.63 | -8.31 | -10.93 | -9.80 | -15.03 | -9.16 | 0.50 |
| EPS Growth % | -5.54% | -2.3% | -0.75% | -0.09% | 0.34% | -0.32% | 0.1% | -0.53% | 0.39% | 1.05% |
| EPS (Basic) | -2.00 | -6.60 | -11.55 | -12.63 | -8.31 | -10.93 | -9.80 | -15.03 | -9.16 | 3.30 |
| Diluted Shares Outstanding | 887.33K | 864.81K | 899.73K | 1.49M | 2.01M | 3.16M | 5.17M | 5.94M | 7.23M | 65.29M |
| Basic Shares Outstanding | 887.33K | 864.81K | 899.73K | 1.49M | 2.01M | 3.16M | 5.17M | 5.94M | 7.23M | 9.67M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 776.03K | 741.17K | 1.62M | 8.46M | 6.55M | 18.94M | 82.64M | 43.93M | 24.5M | 2.16M |
| Cash & Short-Term Investments | 767.27K | 585.68K | 1.54M | 8.22M | 6.22M | 17.52M | 79.25M | 42.75M | 19.64M | 1.19M |
| Cash Only | 767.27K | 585.68K | 1.54M | 8.22M | 6.22M | 17.26M | 77.26M | 39.74M | 19.64M | 1.19M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 262K | 1.99M | 3M | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 200K | 17K | 61K | 18K |
| Days Sales Outstanding | - | - | - | - | - | - | 146 | 16.46 | 9.08 | 2.19 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 855K | 526K | 261K | 539K | 266K |
| Days Inventory Outstanding | - | - | - | - | - | - | 328.19 | 26.36 | 30.64 | 16.08 |
| Other Current Assets | 8.76K | 155.49K | 0 | 0 | 34.12K | 507K | 808K | 599K | 3.41M | 0 |
| Total Non-Current Assets | 438.06K | 129.25K | 16.19K | 36.27K | 692.94K | 837K | 4.34M | 10.05M | 8.62M | 28.5M |
| Property, Plant & Equipment | 0 | 18K | 16.19K | 36.27K | 0 | 82K | 1.58M | 5.49M | 6.05M | 2.65M |
| Fixed Asset Turnover | - | - | - | - | - | - | 0.32x | 0.07x | 0.41x | 1.13x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 2.03M | 3.44M | 1.42M | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.64M |
| Other Non-Current Assets | 438.06K | 111.25K | 0 | 0 | 692.94K | 755K | 725K | 1.12M | 1.15M | 208K |
| Total Assets | 1.21M | 870.42K | 1.64M | 8.5M | 7.24M | 19.78M | 86.98M | 53.98M | 33.12M | 30.66M |
| Asset Turnover | - | - | - | - | - | - | 0.01x | 0.01x | 0.07x | 0.10x |
| Asset Growth % | 0.44% | -0.28% | 0.88% | 4.18% | -0.15% | 1.73% | 3.4% | -0.38% | -0.39% | -0.07% |
| Total Current Liabilities | 580.17K | 1.19M | 2.54M | 10.97M | 11.88M | 20.25M | 7.56M | 41.2M | 54.18M | 35.45M |
| Accounts Payable | 165.32K | 949.41K | 864.4K | 1.74M | 2.35M | 2.97M | 3.3M | 2.7M | 1.79M | 657K |
| Days Payables Outstanding | - | 91.36K | 44.38K | 64.83K | 60.37K | - | 2.06K | 273.09 | 101.54 | 39.72 |
| Short-Term Debt | 0 | 0 | 0 | 7.9M | 8.14M | 14.96M | 0 | 33.65M | 44.2M | 29.1M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
| Other Current Liabilities | 8.39K | 0 | 983.6K | 272.43K | 311.63K | 355K | 25K | 10K | 4.12M | -654.83M |
| Current Ratio | 1.34x | 0.62x | 0.64x | 0.77x | 0.55x | 0.94x | 10.93x | 1.07x | 0.45x | 0.06x |
| Quick Ratio | 1.34x | 0.62x | 0.64x | 0.77x | 0.55x | 0.89x | 10.86x | 1.06x | 0.44x | 0.05x |
| Cash Conversion Cycle | - | - | - | - | - | - | -1.58K | -230.27 | -61.82 | -21.44 |
| Total Non-Current Liabilities | 165.32K | 949.41K | 1.94M | 9.64M | 10.49M | 0 | 0 | 1.85M | 2.96M | 2.25M |
| Long-Term Debt | 0 | 0 | 1.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.85M | 2.96M | 2.25M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 580.17K | 1.19M | 4.49M | 10.97M | 11.88M | 20.25M | 7.56M | 43.05M | 57.14M | 37.69M |
| Total Debt | 0 | 0 | 1.94M | 7.9M | 8.14M | 14.96M | 0 | 36.64M | 48.73M | 31.86M |
| Net Debt | -767.27K | -585.68K | 409.25K | -319.12K | 1.92M | -2.3M | -77.26M | -3.11M | 29.09M | 30.68M |
| Debt / Equity | - | - | - | - | - | - | - | 3.35x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -11.09x | -4.42x | -437.61x | -440.58x | - | -71.11x | -116.80x | -988.60x |
| Total Equity | 633.92K | -319.07K | -2.85M | -2.48M | -4.64M | -473K | 79.42M | 10.93M | -24.02M | -7.03M |
| Equity Growth % | -0.2% | -1.5% | -7.93% | 0.13% | -0.87% | 0.9% | 168.9% | -0.86% | -3.2% | 0.71% |
| Book Value per Share | 0.71 | -0.37 | -3.17 | -1.67 | -2.30 | -0.15 | 15.37 | 1.84 | -3.32 | -0.11 |
| Total Shareholders' Equity | 633.92K | -319.07K | -2.85M | -2.31M | -3.82M | 1.9M | 61.67M | -9.68M | -53.83M | -2.5M |
| Common Stock | 12.25K | 13.33K | 14.55K | 27.14K | 40.48K | 64K | 86K | 6K | 9K | 11K |
| Retained Earnings | -2.05M | -7.7M | -17.91M | -36.99M | -53.71M | -88.28M | -138.91M | -228.17M | -294.43M | -254.97M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -408K | 0 | 0 |
| Accumulated OCI | 0 | 0 | -1.03M | -2.03M | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | -161.51K | -814.28K | -2.37M | 17.75M | 20.61M | 29.81M | -4.54M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -1.25M | -4.45M | -6.61M | -8.79M | -13.36M | -21.91M | -40.59M | -70.98M | -52.04M | -33.55M |
| Operating CF Margin % | - | - | - | - | - | - | -81.18% | -188.29% | -21.22% | -11.2% |
| Operating CF Growth % | -19.73% | -2.57% | -0.48% | -0.33% | -0.52% | -0.64% | -0.85% | -0.75% | 0.27% | 0.36% |
| Net Income | -1.78M | -5.65M | -9.52M | -18.17M | -17.27M | -35.89M | -56.13M | -103.24M | -79.26M | 28.43M |
| Depreciation & Amortization | 0 | 3.79K | 7.11K | 9.79K | 14.23K | 23K | 226K | 2.46M | 2.93M | 1.2M |
| Stock-Based Compensation | 333.33K | 747.37K | 1.05M | 1.23M | 1.57M | 2.04M | 15.01M | 19.53M | 11.14M | 6.45M |
| Deferred Taxes | 0 | 0 | -2.36M | 3.7M | 1.83M | 6.5M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 133.33K | 754.95K | 3.66M | 3.1M | 558.6K | 5.33M | 1.87M | 10.98M | 11.56M | -70.14M |
| Working Capital Changes | 393.66K | 444.84K | 559.22K | 1.35M | -63.93K | 83K | -1.57M | -716K | 1.59M | 512K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | -200K | 183K | -44K | 43K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 100.57K | 877.59K | -85.01K | 872.11K | 613.28K | 501K | 174K | -742K | -918K | -59K |
| Cash from Investing | 0 | -21.79K | -5.3K | -26.61K | -27.2K | -55K | -3.72M | -4.74M | 758K | -16.18M |
| Capital Expenditures | 0 | -21.79K | -5.3K | -26.61K | -27.2K | -55K | -1.47M | -1.54M | -242K | -55K |
| CapEx % of Revenue | - | - | - | - | - | - | 2.94% | 4.08% | 0.1% | 0.02% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -21.79K | -5.3K | -26.61K | 0 | 0 | 0 | 0 | 1M | 350K |
| Cash from Financing | 1.18M | 4.3M | 7.56M | 15.5M | 11.38M | 33.01M | 104.31M | 38.21M | 31.17M | 31.28M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | -7.1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -72.2K | -1M | -388.63K | 9.1M | 0 | 274K | 2.26M | 1.46M | 810K | 419K |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -1.25M | -4.48M | -6.61M | -8.81M | -13.38M | -21.97M | -42.06M | -72.53M | -52.28M | -33.61M |
| FCF Margin % | - | - | - | - | - | - | -84.12% | -192.37% | -21.32% | -11.22% |
| FCF Growth % | -19.73% | -2.58% | -0.48% | -0.33% | -0.52% | -0.64% | -0.91% | -0.72% | 0.28% | 0.36% |
| FCF per Share | -1.41 | -5.18 | -7.35 | -5.94 | -6.65 | -6.95 | -8.14 | -12.21 | -7.23 | -0.51 |
| FCF Conversion (FCF/Net Income) | 0.70x | 0.79x | 0.69x | 0.49x | 0.84x | 0.64x | 0.81x | 0.80x | 0.81x | -0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -248.69% | -3589.54% | - | - | - | - | -127.55% | -196.97% | - | - |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | -1368.08% | -800.25% | -232.43% |
| Gross Margin | - | - | - | - | - | - | -17% | -858.62% | -161.83% | -101.6% |
| Net Margin | - | - | - | - | - | - | -10069.4% | -23602.92% | -2617.25% | 1328.58% |
| Debt / Equity | - | - | - | - | - | - | - | 3.35x | - | - |
| Interest Coverage | - | - | -11.09x | -4.42x | -437.61x | -440.58x | - | -71.11x | -116.80x | -988.60x |
| FCF Conversion | 0.70x | 0.79x | 0.69x | 0.49x | 0.84x | 0.64x | 0.81x | 0.80x | 0.81x | -0.84x |
| Revenue Growth | - | - | - | - | - | - | - | -24.6% | 550.4% | 22.15% |
| 2021 | 2022 | |
|---|---|---|
| Royalty | 100M | 100M |
| Royalty Growth | - | 0.00% |
PAVmed Inc. (PAVM) has a price-to-earnings (P/E) ratio of 17.6x. This is roughly in line with market averages.
PAVmed Inc. (PAVM) reported $0.0M in revenue for fiscal year 2024.
PAVmed Inc. (PAVM) grew revenue by 22.1% over the past year. This is strong growth.
PAVmed Inc. (PAVM) reported a net loss of $6.32B for fiscal year 2024.
PAVmed Inc. (PAVM) had negative free cash flow of $3.6M in fiscal year 2024, likely due to heavy capital investments.